Alpine Global Management, LLC Verastem, Inc. Transaction History

Alpine Global Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.06 - $2.1 $65,177 - $129,124	-61,488 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.05 - $3.2 $126,050 - $196,761	61,488 New	61,488 $126,000
Q2 2018 Aug 15, 2018	SELL	$2.88 - $8.67 $29,067 - $87,506	-10,093 Closed	0 $0
Q1 2018 May 16, 2018	SELL	$2.92 - $3.81 $55,249 - $72,089	-18,921 Reduced 65.21%	10,093 $30,000
Q4 2017 Feb 14, 2018	BUY	$2.99 - $4.85 $86,751 - $140,717	29,014	29,014 $89,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.18B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.